Art

J-GLOBAL ID：201802289095015871   Reference number：18A0359518

High-dose mizoribine combined with calcineurin inhibitor (cyclosporine or tacrolimus), basiliximab and corticosteroids for renal transplantation: A Japanese multicenter study

腎臓移植に対するカルシニューリン阻害剤(シクロスポリンまたはタクロリムス),バシリキシマブおよびコルチコステロイドを併用した高用量ミゾリビン:日本人を対象とした多施設研究

Author (10)： Nishioka Tsukasa (Department of Urology, Sakai Hospital, Kindai University Faculty of Medicine, Sakai, Osaka, Japan) ,  Yoshimura Norio (Department of Transplantation and Regenerative Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Ushigome Hidetaka (Department of Transplantation and Regenerative Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan) ,  Watarai Yoshihiko (Department of Transplant and Endocrine Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi, Japan) ,  Nishimura Kenji (Department of Urology, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Hyogo, Japan) ,  Akioka Kiyokazu (Department of Surgery, Omihachiman Community Medical Center, Omihachiman, Shiga, Japan) ,  Nakamura Nobuyuki (Department of Urology, Fukuoka University Hospital, Fukuoka, Japan) ,  Kawakita Mutsushi (Department of Urology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan) ,  Yuzawa Kenji (Department of Surgery, Mito Medical Center, Mito, Ibaraki, Japan) ,  Nakatani Tatsuya (Department of Urology, Osaka City University, Osaka, Japan)
Material： International Journal of Urology (Web)  (Int J Urol (Web))
Volume： 25  Issue： 2  Page： 141-145  Publication year： 2018 
JST Material Number： U0707A  ISSN： 1442-2042  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *kidney transplantation ,...
Semi thesaurus term： two years survival rate ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0359518&from=J-GLOBAL&jstjournalNo=U0707A") }}

Author keywords (5)： calcineurin inhibitors ,  combination therapy ,  cytomegalovirus ,  mizoribine ,  renal transplantation

JST classification (2)： Clinical application of immunotherapeutic agents and blood preparations  (GW22020O) ,  Surgical treatment for urogenital diseases  (GM05030G)

Substance index (4)： Ciclosporin ,  Tacrolimus ,  CHI-621 ,  Mizoribine

Reference (18)：

• Akiyama T, Okazaki H, Takahashi K et al. Mizoribine in combination therapy with tacrolimus for living donor renal transplantation: analysis of a nationwide study in Japan. Transplant Proc. 2005; 37: 843-5.
• Ushigome H, Uchida K, Nishimura K et al. Efficacy and safety of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids in renal transplantation: a Japanese multicenter study. Transplant Proc. 2016; 48: 794-8.
• Mizuno K, Tsujino M, Takada M et al. Studies on bredinin. 1. Isolation, characterization and biological properties. J. Antibiot. 1974; 27: 775-82.
• Ishikawa H. Mizoribine and mycophenolate mofetil. Curr. Med. Chem. 1999; 6: 575-97.
• Amemiya H, Suzuki S, Niiya S, Watanabe H, Kotake T. Synergisitic effect of cyclosporine and mizoribine on survival of dug renal allografts. Transplantation 1988; 46: 768-71.

Terms in the title (12)： 腎臓移植 ,  カルシニューリン阻害剤 ,  シクロスポリン ,  タクロリムス ,  バシリキシマブ ,  コルチコステロイド ,  併用 ,  高用量 ,  ミゾリビン ,  日本人 ,  施設 ,  研究